| P2093 | author name string | Xu Xu | |
| | Mahesh N Samtani | |
| | Partha Nandy | |
| | Holly Kimko | |
| | Richard S Strauss | |
| | Gary J Noel | |
| | Partha Bagchi | |
| P2860 | cites work | Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients | Q35814807 |
| | Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects | Q35879080 |
| | Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. | Q36422630 |
| | In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus | Q36815290 |
| | In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models | Q36932924 |
| | Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity | Q37030780 |
| | Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infections | Q37115687 |
| | Pharmacokinetic and pharmacodynamic profile of ceftobiprole. | Q37126977 |
| | Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141. | Q37733667 |
| | BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis | Q39650937 |
| | Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials | Q42671287 |
| | Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia | Q44873329 |
| | A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections | Q46787486 |
| | Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore | Q58033538 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacodynamics | Q725307 |
| P304 | page(s) | 3371-3374 | |
| P577 | publication date | 2009-06-15 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections | |
| P478 | volume | 53 | |